Study: Head, neck cancer treatment can be improved by immunotherapy drug \
10 min read
\
\

Study: Head, neck cancer treatment can be improved by immunotherapy drug

06-Mar-2022
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
06-Mar-2022 Science
\
Immunotherapy drug strengthens head, neck cancer treatment: Study \
10 min read
\
\

Immunotherapy drug strengthens head, neck cancer treatment: Study

01-Mar-2022
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
01-Mar-2022 Health
\